This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Rhamnolipid-coated W/O/W double emulsion nanoparticles for efficient delivery of doxorubicin/erlotinib and combination chemotherapy
Journal of Nanobiotechnology Open Access 07 December 2021
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jones, D. Avastin-Tarceva combination fails in lung cancer. Nat Biotechnol 27, 108–109 (2009). https://doi.org/10.1038/nbt0209-108
Issue Date:
DOI: https://doi.org/10.1038/nbt0209-108
This article is cited by
-
Rhamnolipid-coated W/O/W double emulsion nanoparticles for efficient delivery of doxorubicin/erlotinib and combination chemotherapy
Journal of Nanobiotechnology (2021)
-
Overcoming disappointing results with antiangiogenic therapy by targeting hypoxia
Nature Reviews Clinical Oncology (2012)
-
Antiangiogenic therapy: impact on invasion, disease progression, and metastasis
Nature Reviews Clinical Oncology (2011)